Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FILIBUVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAÏVE, HCV GENOTYPE 1 INFECTED SUBJECTS https://www.kusajili.fr:443/Trial/Ekp3sNCNGEihpV9E_d3rIQ%24a-phase-2-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-filibuvir-plus-pegylated-inte
I have read and accept the terms of use of the site and the Privacy Policy
Send your message